UK Markets closed

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9000+0.0700 (+3.83%)
At close: 04:00PM EST
1.9200 +0.02 (+1.05%)
After hours: 07:59PM EST
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3344
Avg. Estimate-0.3-0.36-2.43-1.51
Low estimate-0.43-0.4-2.67-2.25
High estimate-0.23-0.32-2.17-1.23
Year ago EPS-0.7-0.9-2.91-2.43
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate5.42M1.33M10.84M5.5M
Low estimate2.5MN/A6.6MN/A
High estimate7M2M13.1M9.6M
Year ago salesN/A2.74M18.26M10.84M
Sales growth (year/est)N/A-51.50%-40.60%-49.30%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.66-0.75-0.87-0.93
Actual EPS-0.7-0.9-1.01-0.87
Difference-0.04-0.15-0.140.06
Surprise %-6.10%-20.00%-16.10%6.50%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.3-0.36-2.43-1.51
7 days ago-0.3-0.36-2.43-1.51
30 days ago-0.25-0.31-2.36-1.4
60 days ago-0.54-0.5-2.79-1.84
90 days ago-0.54-0.5-2.79-1.84
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSPROIndustrySector(s)S&P 500
Current qtr.57.10%N/AN/AN/A
Next qtr.60.00%N/AN/AN/A
Current year16.50%N/AN/AN/A
Next year37.90%N/AN/AN/A
Next 5 years (per annum)36.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A